Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
buy
Hochschild Mining plc

Start price
Target price
Perf. (%)
€1.35
18.03.24
€366.00
18.03.25
15.30%
30.03.24

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
14.29%
29.04.24

Could be very worthwhile Investment >20% year
buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€8.10
27.06.23
€12.00
31.07.26
74.07%
04.02.24

Could be very worthwhile Investment >20% year
buy
NCC Group plc

Start price
Target price
Perf. (%)
€1.03
02.04.23
€1.90
02.04.24
36.89%
03.04.24

Could be worthwhile Investment >10% per year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.29
06.03.23
-
06.03.24
-13.18%
17.03.23

Risky Investment
buy
Genel Energy

Start price
Target price
Perf. (%)
€1.46
02.02.23
-
02.02.24
-30.27%
24.10.23

buy
ITM Power plc

Start price
Target price
Perf. (%)
€1.01
23.01.23
€1.00
23.01.24
-44.87%
24.01.24

Known brand
Very Future proof/growth oriented business model
Growths faster than the competition
Small cyclical dependencies
buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€6.60
03.01.23
€10.00
31.12.25
30.22%
05.05.23

Could be very worthwhile Investment >20% year
buy
ITM Power plc

Start price
Target price
Perf. (%)
€1.01
20.11.22
€1.00
20.11.23
13.11%
26.11.22

Known brand
Very Future proof/growth oriented business model
Growths faster than the competition
Small cyclical dependencies
buy
ITM Power plc

Start price
Target price
Perf. (%)
€1.01
19.11.22
€1.50
19.11.23
-35.20%
20.11.23

buy
ITM Power plc

Start price
Target price
Perf. (%)
€1.08
17.10.22
€2.00
17.10.23
-21.91%
18.10.23

Medium risks for its business
Innovative
Sustainability is important
Significant cyclical dependencies
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.16
27.09.22
-
27.09.23
-4.31%
01.10.22

Risky Investment
buy
ITM Power plc

Start price
Target price
Perf. (%)
€1.28
22.09.22
-
22.10.22
-13.99%
23.10.22

Could be very worthwhile Investment >20% year
buy
ITM Power plc

Start price
Target price
Perf. (%)
€1.27
19.09.22
€2.00
19.09.23
-9.70%
01.10.22

Known brand
Very Future proof/growth oriented business model
Growths faster than the competition
Small cyclical dependencies
RPS Group plc

Start price
Target price
Perf. (%)
€2.38
10.08.22
-
10.08.23
5.29%
11.08.23

Risky Investment
buy
Zeal Network SE

Start price
Target price
Perf. (%)
€35.60
04.04.22
-
04.04.23
-2.81%
05.04.23

buy
Hurricane Energy plc

Start price
Target price
Perf. (%)
€0.044
22.01.22
€0.10
22.01.23
89.62%
23.01.23

Could be worthwhile Investment >10% per year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.02
09.01.22
-
09.01.23
-18.54%
23.01.22

Could be very worthwhile Investment >20% year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.54
03.01.22
-
03.01.23
-14.69%
09.01.22

Risky Investment
buy
Zeal Network SE

Start price
Target price
Perf. (%)
€38.00
23.12.21
-
23.12.22
-14.74%
25.08.22

buy
BHP Group plc

Start price
Target price
Perf. (%)
€25.45
14.12.21
€33.00
14.06.22
13.16%
18.05.22

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Undervalued
Higher EBIT margin than peer group
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.26
12.12.21
-
12.12.22
9.82%
25.12.21

Could be very worthwhile Investment >20% year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.28
02.12.21
-
02.12.22
-0.61%
11.12.21

Risky Investment
buy
Drax Group

Start price
Target price
Perf. (%)
€6.55
30.11.21
-
30.11.22
19.08%
02.03.22